Assessing Factors in Tinnitus Patients' Clinical Study Experiences
Examining Variables Affecting Patient Participation in Clinical Trials for Tinnitus
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in tinnitus clinical studies, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with tinnitus who may be invited to participate in clinical research in the years to come.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2023
CompletedFirst Posted
Study publicly available on registry
April 13, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 13, 2023
March 1, 2023
1 year
March 31, 2023
March 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of tinnitus patients who decide to enroll in a clinical study
3 months
Rate of tinnitus patients who remain in a clinical study to completion
12 months
Eligibility Criteria
Tinnitus patients who are actively considering participating in an observational medical study, but have not yet completed enrollment and randomization.
You may qualify if:
- Diagnosed with tinnitus
- Willing to comply with all study related procedures and assessments
- Ability to understand and the willingness to sign a written informed consent document.
You may not qualify if:
- No documented diagnosis of tinnitus
- Any other health problems that would prohibit safe participation in the study
- Pregnant or planning to become pregnant while enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Natalini E, Fioretti A, Riedl D, Moschen R, Eibenstein A. Tinnitus and Metacognitive Beliefs-Results of a Cross-Sectional Observational Study. Brain Sci. 2020 Dec 23;11(1):3. doi: 10.3390/brainsci11010003.
PMID: 33374519BACKGROUNDFarr MR, Moraleda Deleito J, Xu Y, Ray J. Developing a one-stop tinnitus service: outcomes of a joined up management strategy: a retrospective observational cohort study. J Eval Clin Pract. 2016 Feb;22(1):93-97. doi: 10.1111/jep.12442. Epub 2015 Aug 28.
PMID: 26314274BACKGROUNDTinnitus Retraining Therapy Trial Research Group; Scherer RW, Formby C. Effect of Tinnitus Retraining Therapy vs Standard of Care on Tinnitus-Related Quality of Life: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2019 Jul 1;145(7):597-608. doi: 10.1001/jamaoto.2019.0821.
PMID: 31120533BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael B Gill
Power Life Sciences Inc.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2023
First Posted
April 13, 2023
Study Start
April 1, 2024
Primary Completion
April 1, 2025
Study Completion
April 1, 2026
Last Updated
April 13, 2023
Record last verified: 2023-03